YaSheng Group
YaSheng Group Fundamental Analysis
YaSheng Group (HERB) shows moderate financial fundamentals with a PE ratio of 0.31, profit margin of 33.42%, and ROE of 2.92%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 59.9/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze HERB's fundamental strength across five key dimensions:
Efficiency Score
WeakHERB struggles to generate sufficient returns from assets.
Valuation Score
ExcellentHERB trades at attractive valuation levels.
Growth Score
ModerateHERB shows steady but slowing expansion.
Financial Health Score
ExcellentHERB maintains a strong and stable balance sheet.
Profitability Score
ExcellentHERB achieves industry-leading margins.
Key Financial Metrics
Is HERB Expensive or Cheap?
P/E Ratio
HERB trades at 0.31 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, HERB's PEG of 0.00 indicates potential undervaluation.
Price to Book
The market values YaSheng Group at 0.01 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 1.41 times EBITDA. This is generally considered low.
How Well Does HERB Make Money?
Net Profit Margin
For every $100 in sales, YaSheng Group keeps $33.42 as profit after all expenses.
Operating Margin
Core operations generate 29.81 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $2.92 in profit for every $100 of shareholder equity.
ROA
YaSheng Group generates $2.78 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
YaSheng Group produces operating cash flow of $5.49M, showing steady but balanced cash generation.
Free Cash Flow
YaSheng Group generates strong free cash flow of $2.74M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.02 in free cash annually.
FCF Yield
HERB converts 1.09% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
0.31
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.003
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.009
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.10
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.001
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.24
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.03
vs 25 benchmark
ROA
Return on assets percentage
0.03
vs 25 benchmark
ROCE
Return on capital employed
0.03
vs 25 benchmark
How HERB Stacks Against Its Sector Peers
| Metric | HERB Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 0.31 | 22.36 | Better (Cheaper) |
| ROE | 2.92% | 1238.00% | Weak |
| Net Margin | 33.42% | -5096.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 1.23 | Strong (Low Leverage) |
| Current Ratio | 3.24 | 2.47 | Strong Liquidity |
| ROA | 2.78% | -191995.00% (disorted) | Weak |
HERB outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews YaSheng Group's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Dividend, Low Volatility
EPS CAGR
N/A
Industry Style: Defensive, Dividend, Low Volatility
FCF CAGR
N/A
Industry Style: Defensive, Dividend, Low Volatility